SCHEMBL810350

SCHEMBL810350

[O]c1ccccc1CCO

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.44
APOBEC3G Q9HC16 1/20 0.39
PTPN1 P18031 2/20 0.39
FFAR1 O14842 1/20 0.37
KMT2A Q03164 2/20 0.33
HPGD P15428 2/20 0.33
FOLH1 Q04609 2/20 0.33
TAAR1 Q96RJ0 1/20 0.33
HSPA5 P11021 1/20 0.33
AKR1B1 P15121 1/20 0.33
KDM4E B2RXH2 1/20 0.33
MEN1 O00255 1/20 0.33
APAF1 O14727 1/20 0.33
MAP2K7 O14733 1/20 0.33
NPC1 O15118 1/20 0.33
GMNN O75496 1/20 0.33
TDP2 O95551 1/20 0.33
ALDH1A1 P00352 1/20 0.33
LMNA P02545 1/20 0.33
PLA2G1B P04054 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5184811 0.84 CYP4F2 (0.38) TDP1APOBEC3GCYP4F2CYP4A11CA2
SCHEMBL8698489 0.84 TAAR1 (0.35) APOBEC3GFOLH1TAAR1HSPA5AKR1B1
SCHEMBL29534868 0.81 TDP1 (0.55) TDP1APOBEC3GPTPN1FFAR1TAAR1
SCHEMBL31203 0.81 TDP1 (0.55) TDP1APOBEC3GPTPN1FFAR1TAAR1
SCHEMBL1438428 0.79
SCHEMBL16236326 0.76 SLC6A2 (0.34) APOBEC3G
SCHEMBL3022571 0.75 GABRA1 (0.48) TDP1PTPN1FFAR1ALDH1A1MAPT
SCHEMBL6829700 0.75 ALDH1A1 (0.34) APOBEC3GTAAR1ALDH1A1TSHRMAPK1
SCHEMBL98102 0.75 TAAR1 (0.56) TAAR1CYP1A2CYP3A4CYP2D6NFKB1
SCHEMBL186669 0.75 GABRA1 (0.37) HPGDKDM4EALDH1A1MAPTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009023669-A1 SUBSTITUTED 5,6,7,8-TETRAHYDROQUINOLINE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE THEREOF JANSSEN PHARMACEUTICA N.V. (BE) 2009-02-19 WO claimed
US-20090048295-A1 SUBSTITUTED 5,6,7,8-TETRAHYDROQUINOLINE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE THEREOF JANSSEN PHARMACEUTICE N.V. (BE) 2009-02-19 US claimed
US-4622169-A ANTHRAQUINONE OR NAPHTHAQUINONE SUBSTITUTED WITH AMINO GROUP REACTED WITH METAL SALT THE DOW CHEMICAL COMPANY (US) 1986-11-11 US claimed
US-10370536-B2 Resin composition, prepreg, resin sheet, metal foil-clad laminate, and printed wiring board MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2019-08-06 US disclosed
EP-3115418-B1 RESIN COMPOSITION, PREPREG, RESIN SHEET, METAL-FOIL-CLAD LAMINATED PLATE, AND PRINTED WIRING BOARD MITSUBISHI GAS CHEMICAL CO (JP) 2018-05-23 EP disclosed
US-20170158854-A1 RESIN COMPOSITION, PREPREG, RESIN SHEET, METAL-FOIL-CLAD LAMINATED PLATE, AND PRINTED WIRING BOARD MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2017-06-08 US disclosed
EP-3115418-A1 RESIN COMPOSITION, PREPREG, RESIN SHEET, METAL-FOIL-CLAD LAMINATED PLATE, AND PRINTED WIRING BOARD Mitsubishi Gas Chemical Company, Inc. (JP) 2017-01-11 EP disclosed
EP-1971611-B1 ANTI-VIRAL COMPOUNDS ABBOTT LAB (US) 2012-10-10 EP disclosed
EP-1702919-B1 NOVEL 2-HETEROARYL-SUBSTITUTED BENZIMIDAZOLE DERIVATIVE MSD KK (JP) 2012-05-30 EP disclosed
EP-2345652-A1 Antiviral compounds Abbott Laboratories (US) 2011-07-20 EP disclosed
US-7915411-B2 Anti-viral compounds ABBOTT LABORATORIES (US) 2011-03-29 US disclosed
EP-1702919-A1 NOVEL 2-HETEROARYL-SUBSTITUTED BENZIMIDAZOLE DERIVATIVE BANYU PHARMACEUTICAL CO., LTD. (JP) 2006-09-20 EP disclosed
EP-1063252-B1 FLAME-RETARDANT RESIN, COMPOSITION THEREOF, AND PROCESS FOR PRODUCING THE SAME OTSUKA KAGAKU KK (JP) 2005-06-08 EP disclosed
US-6797750-B2 Flame-retardant epoxy resin composition, molded article thereof, and electronic part OTSUKA KAGAKU KABUSHIKI KAISHA (JP) 2004-09-28 US disclosed
US-6632891-B1 Obtained by an ester exchange reaction between the flame retardant phosphazene and the polycarbonate or polyester resin OTSUKA KAGAKU KABUSHIKI KAISHA (JP) 2003-10-14 US disclosed
US-20030114606-A1 A phosphazene compound or polyphosphazenes; fireproofing OTSUKA KAGAKU KABUSHIKI KAISHA (JP) 2003-06-19 US disclosed
EP-1273608-A1 FLAME-RETARDANT EPOXY RESIN COMPOSITION, MOLDED OBJECT THEREOF, AND ELECTRONIC PART OTSUKA KAGAKU KABUSHIKI KAISHA (JP) 2003-01-08 EP disclosed
EP-1063252-A1 FLAME-RETARDANT RESIN, COMPOSITION THEREOF, AND PROCESS FOR PRODUCING THE SAME OTSUKA KAGAKU KABUSHIKI KAISHA (JP) 2000-12-27 EP disclosed
US-5006542-A Cardiovascular agents E. R. SQUIBB & SONS, INC. (US) 1991-04-09 US disclosed
US-4622169-A ANTHRAQUINONE OR NAPHTHAQUINONE SUBSTITUTED WITH AMINO GROUP REACTED WITH METAL SALT THE DOW CHEMICAL COMPANY (US) 1986-11-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090048295-A1 SUBSTITUTED 5,6,7,8-TETRAHYDROQUINOLINE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE THEREOF C3AR1, C5AR1, C5AR2 TDP1 3195/4885APOBEC3G 2314/4885PTPN1 3500/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.